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BPHAbstract A recent study reported that Panax ginseng (P. ginseng) has a protective effect on the
development of benign prostatic hyperplasia (BPH). KH053 is used as a new herbal prescription
consisting of P. ginseng and bee-pollen. The present study aimed to investigate whether the
KH053 has inhibition effects on the development of benign prostatic hyperplasia (BPH) using an
animal model with testosterone induced BPH. The experiment was carried out in forty male Wistar
7 week old rats that were divided into four groups (control group, BPH group, positive group, and
KH053 group). One group was used as the control and the three groups received subcutaneous
injections of testosterone 20 mg/kg for 4 weeks to induce BPH. One of them received KH053 by
oral gavage daily at doses of 200 mg/kg concurrently with the testosterone. The positive group
received finasteride at a dose of 1 mg/kg with testosterone. After 4 weeks, all rats were sacrificed
and analyzed for prostate weight, and growth factors. Results revealed that, compared to rats in
the BPH group, KH053 showed that the prostate weight and dihydrotestosterone (DHT) levels
in serum were significantly decreased and the decreases in hyperplasia in prostate were also
observed. In addition, immunohistochemistry (IHC) also revealed that the protein expressions ofd benign
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prostatic hyperplasia in male Wistar rats. Sagrowth factors [transforming growth factor b1 (TGF-b1) and vascular endothelial growth factor
(VEGF)] in prostate tissue were decreased in the KH053 group. In conclusion, these results suggest
that KH053, comprising P. ginseng and bee-pollen, inhibits the development of BPH in Wistar rat
model and might be used as functional food for BPH.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Benign prostatic hyperplasia (BPH) is one of the urological
diseases in old men. The incidence of BPH shows about 50–
60% in men at ages 40–60 and greater than 90% in men over
80 (Isaacs and Coffey, 1989). BPH is characterized by an
enlargement of the prostate surrounding the urethra leading
to constriction of the urethra (Yono et al., 2008). And also
BPH is characterized by hyper-proliferation of the epithelium
and stromal region (McNeal, 1978). These characters of
BPH result in voiding problems manifested by difficulty of uri-
nation and irritative symptoms respectively (Andersson and
Russell, 1990). Although the etiology of BPH has been exactly
unknown, it was suggested that sex hormones namely andro-
gen, testosterone, and dihydrotestosterone (DHT) might con-
tribute to prostatic enlargement in BPH. The a1-adrenergic
receptor (a1-AR) antagonists are the initial drugs for treating
BPH (O’Leary, 2003). And the 5-alpha-reductase inhibitors
block the action of 5-alpha-reductase, the enzyme that con-
verts from testosterone into DHT (Carson and Rittmaster,
2003).
The activity of 5-alpha-reductase inhibitors results in an
increased testosterone level and decreased DHT level. 5-
alpha-reductase inhibitors are used to treat baldness, BPH
and prostate cancer. However, the drug has limitations
because of its side effects, such as decreased libido, erectile dys-
function, and nasal congestion (DuBeau and Resnick, 1992).
Thus, alternative herbal-based therapy has been investigated
(Bailey et al., 2007). Medicinal plants have various applica-
tions in the treatment of diseases (Balamurugan, 2015). Recent
studies showed that a commonly used medicinal plant has an
effective effect on the treatment of BPH or an inhibited effect
on the development of BPH. Kim et al. (2014) showed that
Panax ginseng has an inhibited effect on BPH in the animal
BPH model. Another research also reported that Red ginseng
and 20(S)-Rg3 regulated testosterone-induced prostate hyper-
plasia by deregulating androgen receptor signaling (Bae
et al., 2012). Ginseng has been known as the name of the root
of P. ginseng. It is variously used to treat specific diseases, as
traditional medicine in East Asia. And numerous studies
showed that P. ginseng has protective effects against degener-
ative and aging diseases, such as neurodegenerative diseases
(Cho, 2012), anti lipid accumulation (Yang et al., 2014), dia-
betic nephropathy (Quan et al., 2013), osteoporosis (Siddiqi
et al., 2013), regulating the inflammatory response (Kim
et al., 2015), ischemia, oxidative stress (Lim et al., 2013), and
potential chemopreventive effects (Kim et al., 2013; Sharma
and Goyal, 2015).
Bee-collected pollen is an apicultural product. It includes
nutritionally valuable substances and considerable amounts
of biologically active substances (Cheng et al., 2013). It is also
rich in carbohydrates, crude fibers, lipids, vitamins, and phe-et al., A herbal formula, comprising Pa
udi Journal of Biological Sciences (2015nolic compounds (Feas et al., 2012). However, the specific
chemical composition of bee pollen depends strongly on the
bees’ species, botanical and geographic origin (Pascoal et al.,
2014). Several studies reported that it has various effects to
strengthen the resistance of the body to diseases. Elberry
et al. (2011) showed that date palm pollen treatment reduced
the number of prostatic acini in the BPH rat model and
decreased the production of pro-inflammatory cytokines. In
the present study, the mixture of P. ginseng and bee pollen is
designed as formula KH053. The effect of KH053 on a
testosterone-induced BPH rat model was determined.2. Materials and methods
2.1. Plant material
The dried roots of P. ginseng and bee pollen were used (Dong-
sung Pharmaceuticals, Seoul, Republic of Korea). They were
identified by Dr. Sang-Won Lee in National Institute of Hor-
ticultural and Herbal Science (NIHHS), and voucher speci-
mens (numbers KH13 and H14) were deposited with
Department of Medicinal Crop Research Institute, NIHHS,
Eumsung. We selected P. ginseng for this research. P. ginseng
is sensitive to high heat. As P. ginseng grows the precious
plants are taken great care daily to insure the highest quality.
The P. ginseng garden is covered with straw to control weeds
and protect the sensitive young plants from the long cold
winter.
2.2. Preparation of KH053
The dried roots of P. ginseng and bee pollen were extracted
separately with 100% water for 6 h in a reflux apparatus. After
refluxing, the extracts were filtered, the filtrates were evapo-
rated in a rotary evaporator, and the samples were lyophilized
in a freeze dryer (Operon, Gyeonggi, Republic of Korea). The
extract yields of P. ginseng, was 21%. Each herb of KH053
was mixed in the following ratio: P. ginseng:A. japon-
ica= 12:28. The KH053 was dissolved in distilled water and
sequentially passed through 0.22-lm filters for sterilization.
2.3. Animals
Seven-week-old male Wistar rats with an average body weight
of 250 ± 10 g were brought from animal company (Central
Lab Animal Inc., Seoul, Korea). The animal room was always
regulated at 22 ± 2 C and at 40–70% relative humidity with a
12-h light/dark cycle. All experiments were performed accord-
ing to the protocols approved by the Animal Care Committee
of the Animal Center at Kyung Hee University [KHUASP
(SE)-13-024].nax ginseng and bee-pollen, inhibits development of testosterone-induced benign
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Table 1 Body weight gains in each group.
Group Initial
weight
(g)
Final weight
(g)
Total body weight
gains for 30 days (g)
Control 250 361.00 ± 8.58 111.00 ± 8.59
BPH 250 355.57 ± 5.03 105.57 ± 5.04
KH053 250 357.86 ± 19.74 107.86 ± 19.75
Finasteride 250 356.33 ± 11.83 106.33 ± 11.84
Values are presented as mean ± standard error (n= 10).
Control, not treated group; BPH, testosterone induced BPH group;
KH053, testosterone induced BPH with KH053 (200 mg/kg) group;
finasteride, testosterone induced BPH with finasteride (1 mg/kg. p.
o.) group.
Table 2 Total protein, AST and ALT serum level in each
group.
Group Total protein (g/dL) AST (U/L) ALT (U/L)
Control 3.06 ± 0.19 57.12 ± 5.20 25.75 ± 1.53
BPH 4.02 ± 0.35 82.29 ± 6.36 36.00 ± 4.58
KH053 3.60 ± 0.15 59.00 ± 6.87 29.50 ± 2.50
Finasteride 3.26 ± 0.13 66.38 ± 6.51 27.5 ± 1.95
Values are presented as mean ± standard error (n= 10).
Control, not treated group; BPH, testosterone induced BPH group;
KH053, testosterone induced BPH with KH053 (200 mg/kg) group;
finasteride, testosterone induced BPH with finasteride (1 mg/kg. p.
o.) group.
Table 3 Prostate weight in each group.
Group Prostate (g)
Control 0.84 ± 0.03
BPH 1.94 ± 0.07###
KH053 1.63 ± 0.06**
Finasteride 1.66 ± 0.07**
Values are presented as mean ± standard error (n= 10).
Control, not treated group; BPH, testosterone induced BPH group;
KH053, testosterone induced BPH with KH053 (200 mg/kg) group;
finasteride, testosterone induced BPH with finasteride (1 mg/kg.
p.o.) group.
### P< 0.001 compared with the control group.
** P< 0.01 compared with the BPH group.
Panax ginseng and bee-pollen for inhibition of hyperplasia in rats 32.4. Induction of BPH and treatments
Firstly, the testis organ of the rats was removed to exclude the
influence of intrinsic testosterone except for the rats in the con-
trol group. The spermatic cord and blood vessels were ligated
with Silkam sutures 3/8–16 mm (B. Braun Surgical SA, Rubi,
Spain) and the testis organ was resected. In order to induce
BPH in rats, a subcutaneous injection of testosterone
(20 mg/kg; Wako chemicals, Tokyo, Japan) for 4 weeks after
castration was carried out. And, next day, rats were divided
into 4 groups (each group, n= 10): (1) control group, (2)
testosterone-induced (subcutaneous) BPH group, and (3)
KH053 treated group (200 mg/kg oral administration). (4)
Finasteride (Sigma–Aldrich, St. Louis, MO, USA) treat group
as positive group. Based on a previous study, we treated rats
with 200 mg/kg of KH053 (Hong et al., 2013; Kim et al.,
2014). All materials were administered to the animals in the
morning for 30 days.
2.5. Blood collection and biochemical analysis
After 4 weeks, all rats were fasted overnight. Blood was
obtained from the heart of the rat. Blood was collected in a
serum separating tube (SST tube). Blood samples were cen-
trifuged at 3000g for 15 min. The serum was separated from
blood and stored at 20 C. The total protein, glutamic oxa-
loacetic transaminase (GOT, AST), glutamic pyruvic transam-
inase (GPT, ALT), and DHT levels were analyzed by Green
lab (Seoul, Korea). After the animals were sacrificed, the tissue
of prostate was stored in formaldehyde solution in order to
evaluate pathological change and expression of growth factors.
2.6. Histopathological examination
Prostate tissues embedded in paraffin wax were cut into 10-
lm-thick sections using a microsection machine. Staining with
hematoxylin and eosin was firstly performed. The stained pros-
tate tissues were mounted and cover slipped using mounting
solution and then examined under a microscope.
2.7. Immunohistochemistry (IHC)
After deparaffinization in prostate tissues, immune histochem-
istry (IHC) was performed on 10-lm-thick sections. Antigen
retrieval was performed using citrate buffer, pH 6.0, for
10 min prior to peroxide quenching with 3% H2O2 in phos-
phate buffered saline (PBS) for 15 min. The prostate tissues
were then washed in PBS and preblocked with normal goat
or rabbit serum for 10 min. For reaction with primary anti-
body, slides were incubated with anti-transforming growth fac-
tor – b1 (TGF-B1) (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) in a 1:200 dilution and then anti-vascular endothe-
lial growth factor (VEGF) (Santa Cruz Biotechnology) in a
1:500 dilution overnight at 4 C. The sections were then incu-
bated with biotinylated secondary antibodies (1:1000) for 1 h.
Following a washing step with PBS, streptavidin–horseradish
peroxidase was applied. Finally, the sections were rinsed in
PBS and developed with diaminobenzidine tetrahydrochloride
substrate for 10 min. At least three random fields of each sec-
tion were examined at 100 (Kim et al., 2014).Please cite this article in press as: Park, H.K. et al., A herbal formula, comprising Pa
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All the values are presented as mean avera ± standard error.
The differences of values between the groups were statistically
analyzed by a one-way analysis of variance (ANOVA), fol-
lowed by a nonparametric post hoc Tukey test. All P-values
are two-tailed and significance was considered as P< 0.05.
All statistical analyses were performed using PASW Statistics
ver. 22.0 (SPSS Inc., Chicago, IL, USA).nax ginseng and bee-pollen, inhibits development of testosterone-induced benign
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Figure 1 Effects of KH053 on the DHT levels in serum. Control,
not treated group; BPH, testosterone induced BPH group;
KH053, testosterone induced BPH with KH053 (200 mg/kg)
group; finasteride, testosterone induced BPH with finasteride
(1 mg/kg. p.o.) group. ###P< 0.001 compared with the control
group. *P< 0.05 compared with the BPH group.
Figure 2 Histological examination. Control, not treated group; BPH
BPH with KH053 (200 mg/kg) group; finasteride, testosterone indu
compared with the control group. **P< 0.01 and ***P< 0.01 compa
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3.1. Effect of KH053 on weight change
Body weight gains in each group are presented in Table 1. The
final body weight was measured after 4 weeks. Each group
showed an increase compared to that of the initial body weight
(control group, 111.00 ± 8.59; BPH group, 105.57 ± 5.04;
KH053 group, 107.86 ± 19.75; finasteride group; 106.33
± 11.84). The differences in weight change among the groups
did not show any significant (P> 0.05).
3.2. Effect of KH053 on total protein, AST, and ALT levels in
serum
In order to evaluate toxicity in the liver, AST and ALT were
tested. The AST and ALT levels in serum were not signifi-
cantly different among groups (Table 2). KH053 did not pro-
mote the activity of the serum toxicity marker enzymes, such
as AST and ALT. It is indicated that rats of each group had
a normal function of livers. Total protein levels in the serum
of the BPH group were slightly increased compared to that
of the control group. However, the differences among the
groups did not show any significance (P> 0.05). The total, testosterone induced BPH group; KH053, testosterone induced
ced BPH with finasteride (1 mg/kg. p.o.) group. ###P< 0.001
red with the BPH group.
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pared to those of the control (P> 0.05).
3.3. Effect of KH053 on the prostate
Prostate weights of rats in the BPH group (1.94 ± 0.07 g)
showed a significant increase compared to those of rats in
the control group (0.84 ± 0.03 g; P< 0.001) (Table 3).
KH053 treated groups (1.63 ± 0.06 g, P< 0.01) showed sig-
nificant decreases in prostate weights compared with those of
the BPH group. Prostate weights in the finasteride group were
also decreased markedly compared with the BPH group. These
results were similar to those for the KH053-treated group.
3.4. Measurement of DHT levels in the serum
The BPH group showed a significant increase in serum DHT
level (345 ± 8.17 pg/mL, P < 0.01) compared with the con-
trol group (159 ± 8.34 pg/mL; Fig. 1). In contrast, the
finasteride-treated group showed a significantly reduced serum
DHT level (250.57 ± 25.68 pg/mL, P< 0.01) compared with
the BPH group. Similarly to finasteride-treated group, the
KH053-treated groups showed significant reduction in DHT
levels (249.86 ± 35.07 pg/mL in the 200 mg/kg group,
P< 0.05) compared with the BPH group.Figure 3 The expressions of TGF-b1 and VEGF immunohistochem
group; BPH, testosterone induced BPH group; KH053, testostero
testosterone induced BPH with finasteride (1 mg/kg. p.o.) group. To d
on BPH, the expression of TGF-b1 and VEGF in the rat prostates w
showed TGF-b1 and VEGF are rarely expressed in normal prostat
Immunohistochemical detection also revealed an increase in TGF-b1 a
group. A moderate expression of TGF-b1 and VEGF was also observed
the level of VEGF was significantly higher in the BPH group, while no
with the finasteride group.
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As shown in Fig. 2, there was no change in the histoarchitec-
ture of prostate gland in the control group. The prostate tissue
was tightly packed; epithelium was cuboidal and regular in
size. However, the prostate of the BPH group showed prostatic
epithelial hyperplasia (P< 0.001). The epithelial cell layer and
stromal cell space in the BPH group were larger. KH053-
treated rats significantly showed a reduction in both epithelial
size and thickness of epithelial layer compared with that of the
BPH group, which was similar to the reduction in finasteride
group.3.6. Expression of VEGF and TGF-b1 in prostate tissue
In order to examine the effects of the administration of KH053
on the expression of growth factors in prostate tissue, In Fig. 3,
the protein expressions of growth factors (VEGF and TGF-b1)
in the BPH group were increased than those of the control
group (P< 0.05). These protein expressions of VEGF and
TGF-b1 in both the KH053 group and the finasteride group
observed a decrease compared with those of the BPH group
(P< 0.05).istry of prostate tissue from the rats (100). Control, not treated
ne induced BPH with KH053 (200 mg/kg) group; finasteride,
eterminate a mechanism which could explain the effects of KH053
ere examined. As shown in Fig. 2, immunohistochemical results
e, weak labeling observed in prostatic tissues in control group.
nd VEGF expression in prostatic epithelial cells in the BPH model
in the BPH model group. Immunohistochemical result shows that
significant difference was seen in the KH053 group as compared
nax ginseng and bee-pollen, inhibits development of testosterone-induced benign
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The main objective of this study was to evaluate whether a
KH053 could prevent the development of BPH in an animal
model. BPH showed enlargement of the prostate through a
proliferative process of the stromal and epithelial elements.
KH053 significantly reduced the pathology in inhibiting pros-
tate growth in our results. KH053 treated animals showed sig-
nificant reductions in prostate weights, DHT, and decreased
prostatic epithelial hyperplasia with decreased TGF-b1 and
VEGF expression.
There are two drugs used for BPH therapy. They are
5a-reductase inhibitors (5-ARIs) and a-adrenergic receptor
blockers (Carson and Rittmaster, 2003; O’Leary, 2003). The
a1-adrenergic receptor (a1-ARs) antagonists are the initial
drugs for treating BPH (O’Leary, 2003). 5-ARIs are related
to metabolic transformations of a variety of endogenous ster-
oids. 5-ARIs generally prevent conversion of testosterone,
DHT in androgen-associated disorders. So, 5-ARIs are used
to the treatment of BPH and androgenetic alopecia (Rosen
et al., 2005; Miller and Tarter, 2009). However, the drug has
unfavorable side effects, such as orthostatic hypotension,
decreased libido, and erectile dysfunction (Roehrborn, 2001;
Roehrborn et al., 2002; MacDonald and Wilt, 2005). DHT
connects to nuclear androgen receptors (ARs) on the surface
of stromal and epithelial cells. It activates the transcription
of various growth factors that are mitogenic for the epithelial
and stromal cells of the prostate (Carson and Rittmaster, 2003;
Rittmaster et al., 2008). Thus, an increased DHT level could
contribute to the development of BPH. In our results,
KH053 significantly showed a decreased DHT level.
TGF-b1 has been known as multifunctional cytokine. It
plays an important role in numerous pathways, such as extra-
cellular matrix production and degradation, cell differentia-
tion, proliferation, and apoptosis (Fleisch et al., 2006).
VEGF plays a major role in metastasis and angiogenesis.
VEGF is a major factor in angiogenesis as it influences
endothelial cell growth (Carson and Rittmaster, 2003) and acts
in prostate stimulating the secretion of extracellular matrix ele-
ments, proliferation and angiogenesis, and also contributing to
the glandular hyperplasia. A previous study reported that
DHT could increase the transcription of VEGF and the secre-
tion of biologically active VEGF from human prostatic stroma
(Levine et al., 1998). In our results, KH053 significantly
showed decreased expressions of TGF-b1 and VEGF.
In this study, KH053, comprising P. ginseng and bee-
pollen, treatment in rats induced BPH effectively reduced pros-
tate weight, both epithelial size and thickness of epithelial
layer, DHT level compared to those of rats induced BPH. In
addition, we observed that KH053 contributed to decreased
expressions of TGF-b1 and VEGF in prostate tissues. These
results indicate that KH053 has inhibited effects on the devel-
opment of BPH in an animal model and may be effective
strategies for clinical application of KH053 to BPH. In further
studies, clinical trials need to investigate whether KH053 is
safe, effective for humans and/or BPH patients.
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